https://www.selleckchem.com/pr....oducts/blasticidin-s
Trial Registry NCT00875251 on April 3, 2009. Survivors of germ-cell tumors (GCT) may suffer from long-term adverse consequences. Our study was conducted to assess a long-term sexual functioning in GCT survivors. GCT survivors (N = 17 from the National Cancer Institute in Slovakia completed a Sexual Function Questionnaire that was modified from PROMIS Sexual Function and Satisfaction Questionnaire 9-year median follow up (range 5-32) as a primary exploratory aim. Study groups consisted of 17 survivors (10%) who had active sur
Like
Comment
Share
